Holen Sie sich die Stockscreener-App
0.2148
2.10%
-0.0046
Handel nachbörslich:
.22
0.0052
+2.42%
Schlusskurs vom Vortag:
$0.2194
Offen:
$0.218
24-Stunden-Volumen:
1.29M
Relative Volume:
0.07
Marktkapitalisierung:
$7.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.35M
KGV:
-0.1852
EPS:
-1.16
Netto-Cashflow:
$-19.20M
1W Leistung:
-16.74%
1M Leistung:
-3.68%
6M Leistung:
-54.32%
1J Leistung:
-85.39%
1-Tages-Spanne:
$0.2098
$0.2218
1-Wochen-Bereich:
$0.2098
$0.2603
52-Wochen-Spanne:
$0.1651
$2.03
Theriva Biologics Inc Stock (TOVX) Company Profile
Firmenname
Theriva Biologics Inc
Sektor
Branche
Telefon
301 417 4364
Adresse
9605 Medical Center Drive, Suite 270, Rockville
Vergleichen Sie TOVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.2148 | 7.83M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten
How Theriva Biologics Inc. stock reacts to fiscal policiesPortfolio Return Summary & AI Forecasted Entry/Exit Points - ulpravda.ru
Will Theriva Biologics Inc. stock profit from fiscal stimulusJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - ulpravda.ru
Can Theriva Biologics Inc. stock maintain operating margins2025 Trading Recap & Technical Analysis for Trade Confirmation - ulpravda.ru
Is Theriva Biologics Inc. stock undervalued vs historical averagesOil Prices & Risk Managed Investment Entry Signals - ulpravda.ru
Can Theriva Biologics Inc. stock deliver sustainable ROE2025 Technical Overview & Comprehensive Market Scan Insights - ulpravda.ru
Will Theriva Biologics Inc. stock benefit from green energy trends2026 world cup usa national team semifinals defensive leaders pressing system match prediction preview - ulpravda.ru
Why Theriva Biologics Inc. stock is favored by pension funds2026 world cup usa national team quarterfinals goalkeepers low block defense match prediction statistical analysis - ulpravda.ru
How Theriva Biologics Inc. stock benefits from strong dollar2026 world cup usa national team group stage playmakers possession football winner prediction insights - ulpravda.ru
Theriva Biologics Incto Schedule End-of-Ph - 富途牛牛
Sentiment Watch: Is Theriva Biologics Inc stock at risk of policy regulationJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - moha.gov.vn
Theriva Biologics receives EMA approval for VCN-01 Phase 3 trial - Intellectia AI
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design - Yahoo Finance
Theriva Biologics gains EMA backing for VCN-01 phase 3 - MSN
Theriva receives EMA guidance for pancreatic cancer drug trial design By Investing.com - Investing.com Nigeria
Why Is Theriva Biologics Stock Gaining Monday? - Benzinga
Theriva Biologics stock soars after EMA backs Phase 3 trial design - Investing.com Canada
Theriva Biologics (TOVX) Prepares for Phase 3 Trial with EMA Gui - GuruFocus
Theriva Biologics Announces EMA Advice on Phase 3 Trial for VCN-01 - TradingView — Track All Markets
Theriva Biologics (TOVX) outlines EMA CHMP advice on VCN-01 Phase 3 trial in metastatic pancreatic cancer - Stock Titan
Theriva™ Biologics Announces Positive Scientific Advice - GlobeNewswire
Guidance Update: What market sentiment indicators show for Theriva Biologics Inc. (SFY0) stock2025 Macro Impact & Growth Focused Entry Point Reports - moha.gov.vn
Theriva Biologics (NYSEAMERICAN:TOVX) Trading 5.2% Higher – Here’s Why - Defense World
What drives Theriva Biologics Inc stock priceDebt-to-Equity Ratio Analysis & Free Expert Stock Watchlists - earlytimes.in
Theriva Biologics (TOVX) asks holders to OK 16.18M warrant shares, $8.7M cash - Stock Titan
Have you been able to find a good deal on Theriva Biologics Inc’s shares? - uspostnews.com
Highs Report: Why institutional investors increase stakes in Theriva Biologics Inc. (SFY0) stock2025 Market Sentiment & Safe Swing Trade Setup Alerts - moha.gov.vn
Why Theriva Biologics Inc. stock appeals to dividend investorsJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - Улправда
Hedge Fund Moves: Is Theriva Biologics Inc. stock supported by strong fundamentals2025 Market Overview & Precise Entry and Exit Recommendations - Улправда
Is Theriva Biologics Inc. stock supported by strong fundamentals - Улправда
How risky is Theriva Biologics Inc. stock nowFed Meeting & Free Accurate Trade Setup Notifications - Улправда
Can Theriva Biologics Inc. stock deliver strong Q4 earningsJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - DonanımHaber
Is Theriva Biologics Inc. stock at risk of policy regulationJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - DonanımHaber
What analyst consensus implies for Theriva Biologics Inc. (SFY0) stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - Улправда
Is Theriva Biologics Inc. stock a fit for income portfoliosJuly 2025 Fed Impact & High Return Stock Watch Alerts - DonanımHaber
Can Theriva Biologics Inc. stock sustain free cash flow growthWeekly Trade Review & Community Verified Swing Trade Signals - Улправда
Will Theriva Biologics Inc. (SFY0) stock draw ESG focused funds2025 Sector Review & Free Expert Approved Momentum Trade Ideas - Улправда
Why analysts recommend Theriva Biologics Inc. stock2025 EndofYear Setup & Fast Gain Stock Trading Tips - Улправда
Theriva Biologics to reschedule special stockholder meeting after lack of quorum - Investing.com Nigeria
Theriva Biologics Reschedules Special Stockholder Meeting - TipRanks
Theriva Biologics reschedules special stockholder meeting - MSN
Theriva Biologics (NYSE American: TOVX) to hold new vote on warrant share issuance - Stock Titan
US Market Recap: How Theriva Biologics Inc SFY0 stock reacts to stronger dollarQuarterly Growth Report & Fast Moving Trade Plans - moha.gov.vn
Earnings Risk: How Theriva Biologics Inc SFY0 stock responds to job market shiftsCPI Data & AI Powered Market Trend Analysis - moha.gov.vn
Why Theriva Biologics Inc. stock is a strong buy call2025 Analyst Calls & AI Driven Stock Reports - Newser
Can Theriva Biologics Inc. (SFY0) stock test all time highs2025 Market Overview & Verified Swing Trading Watchlists - Newser
Why Theriva Biologics Inc. stock gets analyst attention2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How Theriva Biologics Inc. (SFY0) stock reacts to Fed tightening2025 Market Overview & Smart Investment Allocation Insights - Newser
Will Theriva Biologics Inc. stock outperform foreign stocksTake Profit & Daily Profit Focused Stock Screening - Newser
Will Theriva Biologics Inc. stock maintain strong growthQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Can Theriva Biologics Inc. stock reach $200 price targetJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Will Theriva Biologics Inc. stock beat value stocksMarket Movers & Growth Focused Stock Pick Reports - Newser
Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
Kapitalisierung:
|
Volumen (24h):